Due to the putative role of cytotoxic T-cells in RA, symptomatic overlap, and the frequent co-occurrence of LGL leukemia with RA (6, 23), we hypothesized that CD8+ T-cells from RA patients may exhibit a higher prevalence of STAT3 mutations than healthy individuals. The gene discussed is STAT3; the disease is rheumatoid arthritis.